Search

everythinglearnresearchcommunity

for

Search:↓

The girl with autoimmune hair loss might regrow hair within a year, and treatments can help but not prevent recurrence; dermatologist referral and corticosteroids are recommended.

Dermoscopy is becoming essential for diagnosing skin conditions and is expected to be a standard tool for dermatologists.

Skin problems are common in lupus patients and should be treated early to prevent worsening.

Baricitinib reduces inflammation and improves cell health in premature aging cells.

Chemotherapy often causes hair loss, nail changes, and mouth issues, but these are usually manageable.

Apremilast shows promise for several skin conditions but needs more research.

A thorough history and examination are crucial for diagnosing skin diseases, which affect up to a third of people. This includes details about skin lesions, medication, general health, lifestyle, family, and contacts, as well as examining the rash, hair, nails, and mucous membranes. Changes in hair and nails can also indicate other medical and skin disorders.

A woman with undifferentiated connective tissue disease was diagnosed with renal amyloidosis and carpal tunnel syndrome.

Lichen planopilaris is the most common type of scarring hair loss observed, with a variety of symptoms and tissue changes.

Ischemic modified albumin could be a new indicator of oxidative stress in people with alopecia areata.

Nanomaterials can significantly improve wound healing and future treatments may include smart, real-time monitoring.

A woman with EMS showed unusual skin mucinosis without the typical hard skin syndrome, suggesting EMS can cause skin mucinosis.

Oclacitinib effectively treated a skin condition in dogs that didn't respond to other immunosuppressants.

Stress, nutritional issues, and chronic diseases can cause hair loss, and nail changes may signal internal diseases; treatment focuses on the underlying cause.

Hair loss can be caused by stress, infections, drugs, and various diseases, with treatment depending on accurate diagnosis.

Genetic screening for NUDT15 polymorphisms is crucial for patients taking azathioprine, especially in Asians.

A 6-year-old boy developed excessive hair growth after taking diazoxide for low blood sugar.

The book helps veterinarians understand and treat hair loss in animals.

A woman with systemic sclerosis developed a unique scarring hair loss combining features of systemic sclerosis and frontal fibrosing alopecia.

PCOS involves immune system issues and inflammation, possibly leading to autoimmune diseases.

Using CD123 to detect certain immune cells helps diagnose a type of hair loss condition.

Low-dose oral minoxidil effectively reduces hair loss in women with female pattern hair loss.

Recognizing skin symptoms in children can help diagnose and manage serious diseases early.

Thyroid autoimmunity may be involved in some female hair loss, suggesting the need to test for thyroid antibodies in these patients.

Nails can reveal important health information about skin and body conditions.

Prurigo pigmentosa mainly affects middle-aged White and Asian women, often linked to a ketogenic diet, and is best treated with oral antibiotics.

Children's hair loss has many causes and requires careful diagnosis and personalized treatment, including emotional support.

The document discusses a condition causing hair loss after surgery and a type of rosacea affecting the nose, with treatments including surgery and laser therapy.

The 2015 Hair Research Congress concluded that stem cells, maraviroc, and simvastatin could potentially treat Alopecia Areata, topical minoxidil, finasteride, and steroids could treat Frontal Fibrosing Alopecia, and PTGDR2 antagonists could also treat alopecia. They also found that low-level light therapy could help with hair loss, a robotic device could assist in hair extraction, and nutrition could aid hair growth. They suggested that Alopecia Areata is an inflammatory disorder, not a single disease, indicating a need for personalized treatments.

The document concludes that anti-dsDNA antibodies are not unique to SLE and their use as indicators is doubtful, highlighting the need for better understanding and classification of the disease.